Frank Hermann

Biography

Frank Hermann has a strong background in clinical research, development and medical affairs in oncology. He joined 4SC in June 2016 as Medical Director Clinical Development and was promoted to CDO in October 2016. Frank Hermann has several years of experience in medical affairs and clinical research, most recently as Associate Medical Director Immuno-Oncology at Bristol-Myers Squibb. During that time, he shared responsibility for several successful launches of nivolumab, an anti-PD1 antibody, in various tumor indications in Germany and was Medical Monitor and Study Director of two pan-European clinical trials.Frank Hermann is pediatrician by training with several years as resident/research associate in pediatric oncology, hematology and radiology at the University Clinic of Giessen and Marburg. He earned his medical degree from the Johannes Gutenberg University of Mainz. 

Research Interest

 Clinical research, Medical Oncology